MARKETS

BSE Prices delayed by 5 minutes... Prices as on Feb 23, 2018   ABB India 1521.95 [ 0.73% ]ACC 1646.8 [ 0.94% ]Ambuja Cements Ltd. 259.7 [ 1.11% ]Asian Paints Ltd. 1101.9 [ -1.29% ]Axis Bank Ltd. 536.55 [ 1.24% ]Bajaj Auto Ltd. 2988 [ 0.57% ]Bank of Baroda 145.6 [ 1.68% ]Bharti Airtel 425.45 [ 2.26% ]Bharat Heavy Ele 92.9 [ 1.81% ]Bharat Petroleum 430.1 [ 0.62% ]Britannia Ind. 4963.7 [ 2.12% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 595.15 [ 0.90% ]Coal India Ltd. 310.55 [ -0.48% ]Colgate Palm. 1049.9 [ 0.46% ]Dabur India 329.05 [ 0.63% ]DLF Ltd. 225 [ 2.13% ]Dr. Reddy's Labs 2169.25 [ 2.26% ]GAIL (India) Ltd. 458.35 [ -1.63% ]Grasim Inds. 1133.75 [ 2.11% ]HCL Technologies 956.1 [ 1.60% ]HDFC 1824.05 [ 0.35% ]HDFC Bank 1879.8 [ 1.34% ]Hero MotoCorp 3498.65 [ 0.47% ]Hindustan Unilever L 1323 [ -0.16% ]Hindalco Indus. 246.55 [ 2.71% ]ICICI Bank 321.3 [ 1.04% ]IDFC L 52.95 [ 2.42% ]Indian Hotels Co 131.8 [ -0.53% ]IndusInd Bank 1642.9 [ 1.14% ]Infosys 1155.65 [ -0.42% ]ITC Ltd. 269.05 [ 0.71% ]Jindal St & Pwr 264.7 [ 5.37% ]Kotak Mahindra Bank 1079.85 [ 0.67% ]L&T 1302.35 [ 0.86% ]Lupin Ltd. 807.15 [ 0.73% ]Mahi. & Mahi 719.3 [ -0.22% ]Maruti Suzuki India 8705.3 [ 0.63% ]MTNL 23.65 [ -2.47% ]Nestle India 7582.5 [ 0.56% ]NIIT Ltd. 94.55 [ -0.89% ]NMDC Ltd. 130.5 [ 2.84% ]NTPC 162.8 [ 1.43% ]ONGC 190 [ 2.04% ]Punj. NationlBak 113.4 [ -1.09% ]Power Grid Corpo 193.25 [ 1.20% ]Reliance Inds. 934 [ 1.09% ]SBI 276.1 [ 1.28% ]Vedanta 337.5 [ 2.82% ]Shipping Corpn. 73.05 [ 0.14% ]Sun Pharma. 570.2 [ 5.17% ]Tata Chemicals 706.5 [ 1.28% ]Tata Global Beverage 270.8 [ 3.22% ]Tata Motors Ltd. 360.45 [ 0.53% ]Tata Steel 677.8 [ 6.26% ]Tata Power Co. 85.65 [ 0.71% ]Tata Consultancy 3076.9 [ 1.20% ]Tech Mahindra Ltd. 620.4 [ 3.03% ]UltraTech Cement 4115.75 [ 0.29% ]United Spirits 3237.5 [ 2.48% ]Wipro Ltd 294.15 [ 0.60% ]Zee Entertainment En 570.2 [ 0.65% ]

News Details

You can view in detail.
Lupin receives USFDA nod for generic Vibra-Tabs tablets 11/09/2017 14:40

Pharma major, Lupin Ltd said that it has received approval from the US health regulator for generic version of Vibra-Tabs.

"...has received final approval for its Doxycycline Hyclate tablet USP, 100 mg from the United States Food and Drug Administration (FDA) to market in the US," the pharma major said in its filing.

Doxycycline Hyclate tablet is the AB rated generic equivalent of Pfizer Inc's Vibra-Tabs, 100 mg.

The drug is indicated in the treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne.

The company said Doxycycline Hyclate tablet had US sales of USD 149.9 million (in last 12 months ending June 2017) as per IMS MAT June 2017.

Meanwhile, shares of the company were trading at Rs 977.4 apiece, up 0.96 per cent from the previous close at 14:45 hours on BSE.

LOAD MORE